×

Accused fraudster Martin Shkreli reportedly to be lampooned in a new musical

Some enchanted evening, you may raise your drug prices ...

Pharmaceutical bad boy and accused fraudster Martin Shkreli will be lampooned in a satirical new musical in New York, according to a report Wednesday.

Martin Shkreli (C), former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals, departs following a hearing at a U.S. federal court in New York City on June 6, 2016.
Lucas Jackson | Reuters
Martin Shkreli (C), former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals, departs following a hearing at a U.S. federal court in New York City on June 6, 2016.

"Martin Shkreli's Game: How Bill Murray Joined the Wu-Tang Clan" will poke fun at Shkreli's actual, jaw-dropping $2 million purchase of a special, single-copy Wu-Tang Clan album, the New York Post reported. It also will play off of phony reports that a clause in the sale would have allowed the legendary hip-hop group to team up with Murray to steal the album back.

The show, to premiere July 19 at a Manhattan film festival, will feature a song titled "I'm Martin F****** Shkreli and You Can All Go F*** Yourselves."

One line from that profane ditty: "You wonder what I'm worth, the richest damn Albanian to walk the Earth!"

The show's lyricist, Lauren Gundrum, told the Post: "Martin's just such an interesting character."

"Shkreli buying this album is hilarious and so in character," she said.

When asked about the musical, Shkreli's high-powered criminal defense lawyer Benjamin Brafman gave a strong thumbs-down to CNBC.

"Martin and his lawyers intend to ignore this childish, absurd project," Brafman said. "We have far more serious issues to address and will not allow ourselves to be distracted."

Those issues include the eight-count criminal indictment against the 33-year-old Shkreli in federal court in Brooklyn.

The indictment accuses Shkreli of swindling $11 million out of the pharma company he founded, Retrophin, to pay off investors he was suspected of defrauding at hedge funds that he had previously run.

Even before that December indictment, Shkreli was the subject of widespread scorn due to a move by his new company, Turing Pharmaceuticals, to purchase a drug used to treat a parasitic infection that occurred in pregnant women, babies and people with HIV, and then raise the price of the medication by more than 5,000 percent, to $750 per pill.

Shkreli aggressively defended that price hike in repeated media interviews. He then refused to testify to Congress about it, citing his Fifth Amendment right against self-incrimination.

Shkreli has pleaded not guilty to the charges. He remains free on a $5 million bond, and is next due in court July 14.

Read the full New York Post story here.